![Henry Rath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Henry Rath
Keine laufenden Positionen mehr
Profil
Henry Rath worked as an Executive Director of Corporate Development at Amgen, Inc. from 2003 to 2012.
He also worked as a Senior Vice President of Business Development at Seres Therapeutics, Inc. and as a Senior Manager of Strategy and Business Development at Baxter BioScience Corp.
In addition, he was a Vice President of Business Development at Astria Therapeutics, Inc. and a Member of the Biotechnology Group at The Lek.
He was also a Member at Oppenheimer & Co., Inc. Mr. Rath holds an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Harvard College.
He is currently working as the Chief Business Officer at Surface Oncology, Inc.
Ehemalige bekannte Positionen von Henry Rath
| Unternehmen | Position | Ende |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Corporate Officer/Principal | 08.09.2023 |
| AMGEN INC. | Corporate Officer/Principal | 01.05.2012 |
| SERES THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Corporate Officer/Principal | - |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Corporate Officer/Principal | - |
Ausbildung von Henry Rath
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
